Navigation Links
Palomar and Q-MED AB Enter Into International Distribution Agreement
Date:1/9/2008

Q-MED AB to distribute Palomar products outside North America

BURLINGTON, Mass., Jan. 9 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced the execution of an international distribution agreement with the Swedish company Q-MED AB (OMX Nordic Exchange, Stockholm Mid Cap: QMED), a leading biotech/medical device company based in Uppsala, Sweden. Q-MED will eventually be responsible for the marketing, advertising, promotion, sale and distribution of Palomar's professional products for aesthetic treatments outside North America. Q-MED AB is the producer of Restylane, one of the most popular and widely distributed dermal fillers in the world, with over 9 million treatments provided so far. Q-MED AB sells Restylane globally through a network of fully owned sales companies, partners and distributors.

The single source availability of Palomar and Q-MED products will provide physicians with a wide variety of treatment modalities to better meet the needs of their customers for a superior aesthetic treatment. Palomar and Q- MED also recognize that the potential synergistic effects which may be achieved using the current products of both companies may provide improved treatment options to customers. In addition, Palomar and Q-MED will collaborate on marketing campaigns, as well as arranging clinical symposiums, consensus meetings and advisory boards.

The companies intend that Q-MED will be an exclusive distributor in a major portion of Europe by the end of 2008 and a large portion of the rest of the world (excluding North America) by the end of 2009. The transition from Palomar's existing distributors to
'/>"/>

SOURCE Palomar Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
2. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
3. Murray Leads Delegation in Securing $2.1 Million for Proton Therapy Center
4. Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma
5. AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China
6. Nano-Science Center to coordinate EU-project
7. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
8. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
9. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
10. Embla Systems in Collaboration with Beth Israel Deaconess Medical Center to Develop Cardio-Pulmonary Coupling Technology
11. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Caliper Life Sciences, Inc. (Nasdaq: CALP ), ... discovery and life sciences research, today introduced Living Image ... Image software drives the more than 800 Caliper IVIS ... features advanced spectral unmixing tools to enhance fluorescent sensitivity ...
(Date:12/2/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) announced today ... quarter and fiscal year 2009 on December 16, 2009, at ... at 4:45 p.m. ET Martek will conduct a conference call ... may listen to the call live via webcast by visiting ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Neurostimulation - A Global Market Perspective ... The world neurostimulation market stands enthused by ... the resultant rise in age-related diseases such ...
(Date:12/2/2009)... YORK, Dec. 2 Reportlinker.com announces that ... in its catalogue: ,, Drug Discovery ... Trends & Opportunities ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ... integral and ongoing element of every pharmaceutical ...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
... U.S. Department of Energy,s Ames ,Laboratory have come ... and distribute ,the massive amounts of data that ... the world. The new technology, a three-dimensional photonic ... multiple ,wavelength channels (wavelengths of light) traveling along ...
... LLC.,today announced the addition of Mark Scherling to ... FCP as Program,Management Office and Siemens Practice Director., ... thought leadership,experience to FCP. Prior to joining FCP, ... at Catholic Healthcare West. Prior to that,responsibility, Mark ...
... England, February 18 Ranier Technology, a,Cambridge UK ... GBP8,million ($16 million) investment from new and existing ... spinal implant products.,The investment was made by Alliance ... the clinical testing and European launch of CAdisc ...
Other Biology Technology:New filter clears up fiber optic communications 2New filter clears up fiber optic communications 3FCP Welcomes Mark Scherling 2Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 2Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 3
(Date:12/2/2009)... consumption before head and neck cancer diagnosis strongly predicts ... studies. Now, results of a new study show a ... cancer diagnosis. , "Most cancer survivors are counseled to ... study, 21 percent continued to smoke even after their ...
(Date:12/2/2009)... secondhand smoke for a prolonged period of time and ... cancer, even in women who never smoked cigarettes themselves. ... smoke could increase risk of breast cancer is one ... scientist at the Northern California Cancer Center,s Berkeley office. ...
(Date:12/2/2009)... other foods have done more than raise public awareness and ... boom in the market for food testing equipment and fostering ... cover story in the current issue of Chemical & ... Editor Jyllian Kemsley and Senior Correspondent Marc Reisch point out ...
Breaking Biology News(10 mins):Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities 5342 1ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities 5342 2ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities 5342 3Mirixa Corporation Announces Key Pharmacy Network Hire 5339 1Mirixa Corporation Announces Key Pharmacy Network Hire 5339 2AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform 5336 1AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform 5336 2
... susceptible cell, the human immunodeficiency virus hijacks that cell's ... HIV particles roll off the cellular assembly lines, burst ... to invade other cellular factories. Vanderbilt University Medical Center ... particle assembly. The findings, published March 11 in Cell, ...
... of scientists at The Scripps Research Institute is reporting ... research fundamental to everything from the normal processes that ... aberrant mechanisms that underlie many diseases, including cancer and ... RNA known as microRNA and their relationship to the ...
... of Applied Microbiology investigates how bacteria respond when they ... space stations, which feature lowered effects of gravity. , ... by Paul W. Baker and Laura G. Leff describes ... for some species, bacteria from the International Space Station ...
Other Biology News:Shutting down the HIV assembly line 2Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 2Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 3Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 4
A univariate (peak height or area) quantitative multi-component analysis package....
...
... Gene expression profiling allows a high-throuput ... that naturally occuring or artifitially induced changes ... in that system can be detected, studied, ... a broad range of genes at a ...
Rabbit polyclonal to Esa1 ( Abpromise for all tested applications)....
Biology Products: